Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Rex

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?Abigail R Colson, Alec Morton, Christine Årdal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of AmericaPeter G Pappas, Carol A Kauffman, David Andes, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 3, 2019
The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex 'mix-and-match' implementation packageJohn P Hays, Konstantinos Mitsakakis, Saturnino Luz, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2008
Multilaboratory testing of antifungal combinations against a quality control isolate of Candida kruseiVishnu Chaturvedi, Rama Ramani, Mahmoud A Ghannoum, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is NeededMark S Butler, Valeria Gigante, Hatim Sati, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2022
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant <i>Enterobacterales</i> Are Critical Priority Pathogens, Too!"Mark S Butler, Valeria Gigante, Hatim Sati, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2024
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gapsValeria Gigante, Richard A Alm, Daniela Melchiorri, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2021
When to change treatment of acute invasive aspergillosis: an expert viewpointMonica A Slavin, Yee-Chun Chen, Catherine Cordonnier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2021
FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal DrugsElizabeth O'Shaughnessy, Yuliya Yasinskaya, Cheryl Dixon, et al.
The Lancet. Infectious Diseases|January 23, 2016
Alternatives to antibiotics-a pipeline portfolio reviewLloyd Czaplewski, Richard Bax, Martha Clokie, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?Abigail R Colson, Alec Morton, Christine Årdal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of AmericaPeter G Pappas, Carol A Kauffman, David Andes, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 3, 2019
The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex 'mix-and-match' implementation packageJohn P Hays, Konstantinos Mitsakakis, Saturnino Luz, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2008
Multilaboratory testing of antifungal combinations against a quality control isolate of Candida kruseiVishnu Chaturvedi, Rama Ramani, Mahmoud A Ghannoum, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is NeededMark S Butler, Valeria Gigante, Hatim Sati, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2022
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant <i>Enterobacterales</i> Are Critical Priority Pathogens, Too!"Mark S Butler, Valeria Gigante, Hatim Sati, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2024
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gapsValeria Gigante, Richard A Alm, Daniela Melchiorri, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2021
When to change treatment of acute invasive aspergillosis: an expert viewpointMonica A Slavin, Yee-Chun Chen, Catherine Cordonnier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2021
FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal DrugsElizabeth O'Shaughnessy, Yuliya Yasinskaya, Cheryl Dixon, et al.
The Lancet. Infectious Diseases|January 23, 2016
Alternatives to antibiotics-a pipeline portfolio reviewLloyd Czaplewski, Richard Bax, Martha Clokie, et al.
Pageof 10